Equity Overview
Price & Market Data
Price: $3.22
Daily Change: +$0.218 / 6.77%
Range: $3.06 - $3.28
Market Cap: $11,981,620
Volume: 34,169
Performance Metrics
1 Week: 11.81%
1 Month: 1.58%
3 Months: -26.35%
6 Months: -82.12%
1 Year: -87.36%
YTD: -62.38%
Company Details
Employees: 28
Sector: Health technology
Industry: Pharmaceuticals: major
Country: Israel
Details
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It also develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.